Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells

Abstract The solute carrier (SLC) protein family, traditionally recognized for transporting molecules across cell membranes, is gaining attention for its broader roles, including signaling. Among SLC proteins, the ascorbate transporter SVCT2 remains poorly understood, particularly in relation to est...

Full description

Saved in:
Bibliographic Details
Main Authors: Soon Young Jang, Eunbi Hong, Yebin Jo, Jiyun Kim, Jong-Ho Kim, Yuran Na, Chang-Hwan Yeom, Yoon Jung Yang, Emanuela Jacchetti, Manuela Teresa Raimondi, Seyeon Park
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-11758-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332856932794368
author Soon Young Jang
Eunbi Hong
Yebin Jo
Jiyun Kim
Jong-Ho Kim
Yuran Na
Chang-Hwan Yeom
Yoon Jung Yang
Emanuela Jacchetti
Manuela Teresa Raimondi
Seyeon Park
author_facet Soon Young Jang
Eunbi Hong
Yebin Jo
Jiyun Kim
Jong-Ho Kim
Yuran Na
Chang-Hwan Yeom
Yoon Jung Yang
Emanuela Jacchetti
Manuela Teresa Raimondi
Seyeon Park
author_sort Soon Young Jang
collection DOAJ
description Abstract The solute carrier (SLC) protein family, traditionally recognized for transporting molecules across cell membranes, is gaining attention for its broader roles, including signaling. Among SLC proteins, the ascorbate transporter SVCT2 remains poorly understood, particularly in relation to estrogen receptor alpha (ERα), a key regulator in breast cancer cells. Here, we investigate how ERα regulates SVCT2 and its implications for chemoresistance. Our results demonstrate that ERα knockdown significantly reduces SVCT2 protein levels, impairing cellular ascorbic acid uptake. Mechanistically, ERα directly interacts with SVCT2. We show that X-linked inhibitor of apoptosis protein (XIAP), an E3 ubiquitin ligase, targets SVCT2 for ubiquitination and subsequent proteasomal degradation in ERα-deficient conditions. Notably, silencing XIAP restored SVCT2 stability, underscoring its regulatory role. Functionally, ERα or SVCT2 knockdown decreases doxorubicin-induced cytotoxicity, accompanied by increased expression of ATP-binding cassette (ABC) transporter genes, which mediate drug efflux and contribute to chemoresistance. These findings uncover a novel regulatory axis between ERα and SVCT2, mediated by XIAP, and establish SVCT2 as a critical factor in maintaining cellular ascorbic acid levels and drug sensitivity. Targeting XIAP or modulating SVCT2 may represent promising therapeutic strategies for overcoming resistance in ERα-positive breast cancer. This study advances our understanding of the interplay between nutrient transport and cancer therapy, offering new avenues for intervention.
format Article
id doaj-art-e837e8659e8b459d9d4fb0ce9d58dfa9
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e837e8659e8b459d9d4fb0ce9d58dfa92025-08-20T03:46:04ZengNature PortfolioScientific Reports2045-23222025-07-0115111710.1038/s41598-025-11758-5Estrogen receptor α regulates SVCT2 protein level in human breast cancer cellsSoon Young Jang0Eunbi Hong1Yebin Jo2Jiyun Kim3Jong-Ho Kim4Yuran Na5Chang-Hwan Yeom6Yoon Jung Yang7Emanuela Jacchetti8Manuela Teresa Raimondi9Seyeon Park10Department of Applied Chemistry, Dongduk Women’s UniversityDepartment of Applied Chemistry, Dongduk Women’s UniversityDepartment of Applied Chemistry, Dongduk Women’s UniversityDepartment of Applied Chemistry, Dongduk Women’s UniversityDepartment of Pharmacy, Graduate School, Kyung Hee UniversityRappeler Company (4F)Rappeler Company (4F)Department of Food and Nutrition, Dongduk Women’s UniversityDepartment of Chemistry, Materials and Chemical Engineering ‘Giulio Natta, Politecnico Di MilanoDepartment of Chemistry, Materials and Chemical Engineering ‘Giulio Natta, Politecnico Di MilanoDepartment of Applied Chemistry, Dongduk Women’s UniversityAbstract The solute carrier (SLC) protein family, traditionally recognized for transporting molecules across cell membranes, is gaining attention for its broader roles, including signaling. Among SLC proteins, the ascorbate transporter SVCT2 remains poorly understood, particularly in relation to estrogen receptor alpha (ERα), a key regulator in breast cancer cells. Here, we investigate how ERα regulates SVCT2 and its implications for chemoresistance. Our results demonstrate that ERα knockdown significantly reduces SVCT2 protein levels, impairing cellular ascorbic acid uptake. Mechanistically, ERα directly interacts with SVCT2. We show that X-linked inhibitor of apoptosis protein (XIAP), an E3 ubiquitin ligase, targets SVCT2 for ubiquitination and subsequent proteasomal degradation in ERα-deficient conditions. Notably, silencing XIAP restored SVCT2 stability, underscoring its regulatory role. Functionally, ERα or SVCT2 knockdown decreases doxorubicin-induced cytotoxicity, accompanied by increased expression of ATP-binding cassette (ABC) transporter genes, which mediate drug efflux and contribute to chemoresistance. These findings uncover a novel regulatory axis between ERα and SVCT2, mediated by XIAP, and establish SVCT2 as a critical factor in maintaining cellular ascorbic acid levels and drug sensitivity. Targeting XIAP or modulating SVCT2 may represent promising therapeutic strategies for overcoming resistance in ERα-positive breast cancer. This study advances our understanding of the interplay between nutrient transport and cancer therapy, offering new avenues for intervention.https://doi.org/10.1038/s41598-025-11758-5SVCT2Estrogen receptor alphaDegradationXIAPDrug resistanceBreast cancer
spellingShingle Soon Young Jang
Eunbi Hong
Yebin Jo
Jiyun Kim
Jong-Ho Kim
Yuran Na
Chang-Hwan Yeom
Yoon Jung Yang
Emanuela Jacchetti
Manuela Teresa Raimondi
Seyeon Park
Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells
Scientific Reports
SVCT2
Estrogen receptor alpha
Degradation
XIAP
Drug resistance
Breast cancer
title Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells
title_full Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells
title_fullStr Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells
title_full_unstemmed Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells
title_short Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells
title_sort estrogen receptor α regulates svct2 protein level in human breast cancer cells
topic SVCT2
Estrogen receptor alpha
Degradation
XIAP
Drug resistance
Breast cancer
url https://doi.org/10.1038/s41598-025-11758-5
work_keys_str_mv AT soonyoungjang estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT eunbihong estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT yebinjo estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT jiyunkim estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT jonghokim estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT yuranna estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT changhwanyeom estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT yoonjungyang estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT emanuelajacchetti estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT manuelateresaraimondi estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells
AT seyeonpark estrogenreceptoraregulatessvct2proteinlevelinhumanbreastcancercells